Angiotensin II for treating vasosuppressor-resistant hypotension caused by septic or distributive shock (terminated appraisal)

  • Technology appraisal
  • TA859
  • Published: 

History

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators